Kuloglu M - Search Results

1

Serum leptin and cholesterol levels in patients with bipolar disorder.

Atmaca M, Kuloglu M, Tezcan E, Ustundag B, Bayik Y. Atmaca M, et al. Among authors: kuloglu m. Neuropsychobiology. 2002;46(4):176-9. doi: 10.1159/000067809. Neuropsychobiology. 2002. PMID: 12566933

2

Serum leptin and cholesterol values in suicide attempters.

Atmaca M, Kuloglu M, Tezcan E, Ustundag B, Gecici O, Firidin B. Atmaca M, et al. Among authors: kuloglu m. Neuropsychobiology. 2002;45(3):124-7. doi: 10.1159/000054950. Neuropsychobiology. 2002. PMID: 11979060

3

Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder.

Kuloglu M, Ustundag B, Atmaca M, Canatan H, Tezcan AE, Cinkilinc N. Kuloglu M, et al. Cell Biochem Funct. 2002 Jun;20(2):171-5. doi: 10.1002/cbf.940. Cell Biochem Funct. 2002. PMID: 11979513

4

Antioxidant enzyme activities and malondialdehyde levels in patients with obsessive-compulsive disorder.

Kuloglu M, Atmaca M, Tezcan E, Gecici O, Tunckol H, Ustundag B. Kuloglu M, et al. Neuropsychobiology. 2002;46(1):27-32. doi: 10.1159/000063573. Neuropsychobiology. 2002. PMID: 12207144

5

Neopterin levels and dexamethasone suppression test in posttraumatic stress disorder.

Atmaca M, Kuloglu M, Tezcan E, Onal S, Ustundag B. Atmaca M, et al. Among authors: kuloglu m. Eur Arch Psychiatry Clin Neurosci. 2002 Aug;252(4):161-5. doi: 10.1007/s00406-002-0374-5. Eur Arch Psychiatry Clin Neurosci. 2002. PMID: 12242576

6

Weight gain and serum leptin levels in patients on lithium treatment.

Atmaca M, Kuloglu M, Tezcan E, Ustundag B. Atmaca M, et al. Among authors: kuloglu m. Neuropsychobiology. 2002;46(2):67-9. doi: 10.1159/000065414. Neuropsychobiology. 2002. PMID: 12378122 Clinical Trial.

7

Efficacy of citalopram and moclobemide in patients with social phobia: some preliminary findings.

Atmaca M, Kuloglu M, Tezcan E, Unal A. Atmaca M, et al. Among authors: kuloglu m. Hum Psychopharmacol. 2002 Dec;17(8):401-5. doi: 10.1002/hup.436. Hum Psychopharmacol. 2002. PMID: 12457375 Clinical Trial.

8

Antioxidant enzyme and malondialdehyde levels in patients with panic disorder.

Kuloglu M, Atmaca M, Tezcan E, Ustundag B, Bulut S. Kuloglu M, et al. Neuropsychobiology. 2002;46(4):186-9. doi: 10.1159/000067810. Neuropsychobiology. 2002. PMID: 12566935

9

Serum iron levels in schizophrenic patients with or without akathisia.

Kuloglu M, Atmaca M, Ustündag B, Canatan H, Gecici O, Tezcan E. Kuloglu M, et al. Eur Neuropsychopharmacol. 2003 Mar;13(2):67-71. doi: 10.1016/s0924-977x(02)00073-1. Eur Neuropsychopharmacol. 2003. PMID: 12650948

10

Serum leptin and triglyceride levels in patients on treatment with atypical antipsychotics.

Atmaca M, Kuloglu M, Tezcan E, Ustundag B. Atmaca M, et al. Among authors: kuloglu m. J Clin Psychiatry. 2003 May;64(5):598-604. doi: 10.4088/jcp.v64n0516. J Clin Psychiatry. 2003. PMID: 12755665

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

72 results

Search Page

Filters